Follow
Finbarr O'Harte
Finbarr O'Harte
Verified email at ulster.ac.uk - Homepage
Title
Cited by
Cited by
Year
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion
NH McClenaghan, CR Barnett, E Ah-Sing, YHA Abdel-Wahab, ...
Diabetes 45 (8), 1132-1140, 1996
3971996
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes
JR Lindsay, NA Duffy, AM McKillop, J Ardill, FPM O'Harte, PR Flatt, ...
Diabetic Medicine 22 (5), 654-657, 2005
2602005
Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and …
VA Gault, N Irwin, BD Green, JT McCluskey, B Greer, CJ Bailey, P Harriott, ...
Diabetes 54 (8), 2436-2446, 2005
1892005
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1
BD Green, N Irwin, NA Duffy, VA Gault, FPM O'harte, PR Flatt
European journal of pharmacology 547 (1-3), 192-199, 2006
1712006
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese …
VA Gault, FPM O'harte, P Harriott, MH Mooney, BD Green, PR Flatt
Diabetologia 46, 222-230, 2003
1472003
Mechanisms of amino acid-induced insulin secretion from the glucose-responsive BRIN-BD11 pancreatic B-cell line
NH McClenaghan, CR Barnett, FPM O'Harte, PR Flatt
Journal of Endocrinology 151 (3), 349-357, 1996
1431996
Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans
SJ Hunter, AC Boyd, FPM O’Harte, AM McKillop, MI Wiggam, MH Mooney, ...
Diabetes 52 (2), 492-498, 2003
1362003
Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents
BD Green, VA Gault, FPM O'harte, PR Flatt
Current pharmaceutical design 10 (29), 3651-3662, 2004
1352004
Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide
VA Gault, FPM O'Harte, P Harriott, PR Flatt
Biochemical and biophysical research communications 290 (5), 1420-1426, 2002
1302002
Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes
VA Gault, PR Flatt, FPM O’Harte
Biochemical and biophysical research communications 308 (2), 207-213, 2003
1242003
Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda
JM Conlon, F O'Harte, DD Smith, MC Tonon, H Vaudry
Biochemical and biophysical research communications 188 (2), 578-583, 1992
1171992
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
VA Gault, FPM O’Harte, PR Flatt
Neuropeptides 37 (5), 253-263, 2003
1142003
Evidence that the major degradation product of glucose-dependent insulinotropic polypeptide, GIP (3-42), is a GIP receptor antagonist in vivo
VA Gault, JC Parker, P Harriott, PR Flatt, FPM O'Harte
Journal of Endocrinology 175 (2), 525-534, 2002
1132002
Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic …
N Irwin, PL McClean, FPM O’harte, VA Gault, P Harriott, PR Flatt
Diabetologia 50, 1532-1540, 2007
1082007
Glycation of insulin in the islets of Langerhans of normal and diabetic animals
YHA Abdel-Wahab, FP O'Harte, H Ratcliff, NH McClenaghan, CR Barnett, ...
Diabetes 45 (11), 1489-1496, 1996
1051996
Atlantic salmon (Salmo salar) co-product-derived protein hydrolysates: A source of antidiabetic peptides
PA Harnedy, V Parthsarathy, CM McLaughlin, MB O'Keeffe, PJ Allsopp, ...
Food Research International 106, 598-606, 2018
1002018
Methylmalonyl-CoA mutase (EC 5.4. 99.2) and methionine synthetase (EC 2.1. 1.13) in the tissues of cobalt–vitamin B12 deficient sheep
DG Kennedy, A Cannavan, A Molloy, F O'harte, SM Taylor, S Kennedy, ...
British Journal of Nutrition 64 (3), 721-732, 1990
1001990
Identification of the site of glycation of human insulin
FPM O'Harte, P Højrup, CR Barnett, PR Flatt
Peptides 17 (8), 1323-1330, 1996
941996
Impaired ability of glycated insulin to regulate plasma glucose and stimulate glucose transport and metabolism in mouse abdominal muscle
AC Boyd, YHA Abdel-Wahab, AM McKillop, H McNulty, CR Barnett, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1523 (1), 128-134, 2000
802000
NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.
FP O'Harte, MH Mooney, PR Flatt
Diabetes 48 (4), 758-765, 1999
801999
The system can't perform the operation now. Try again later.
Articles 1–20